{"id":"W2949673037","doi":"10.1097/01.hs9.0000558628.70462.93","title":"S102 POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIAL","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Regimen; Follicular lymphoma; Interim analysis; Gastroenterology; Rituximab; Adverse effect; Lymphoma; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001459023,0.0006475523,0.00101645,0.0002254211,0.0002450001,0.001153892,0.0006603578,0.0007881994,0.003568365],"category_scores_gemma":[0.0006457631,0.0003152183,0.001168267,0.0003249169,0.0004168611,0.0005950604,0.0003200083,0.001985807,0.0008221548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000865543,"about_ca_system_score_gemma":0.001494469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006895472,"about_ca_topic_score_gemma":0.002091097,"domain_scores_codex":[0.9996243,0.0002046176,0.00002814631,0.00004464434,0.00003372588,0.00006460191],"domain_scores_gemma":[0.9994942,0.00009873032,0.0001149665,0.00004129792,0.0000351862,0.0002156281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7519876,0.01712739,0.01510799,0.0006828082,0.00180072,0.0002944037,0.000232281,0.003684196,0.03513399,0.0004322299,0.007238879,0.1662777],"study_design_scores_gemma":[0.5350845,0.4152581,0.02561972,0.0001058287,0.001186198,0.0006860421,0.00009032981,0.002561091,0.008260583,0.0003903046,0.0107232,0.00003399361],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893894,0.002692029,0.0003800443,0.0006772302,0.0001104931,0.001389427,0.001397723,0.0001075134,0.003856139],"genre_scores_gemma":[0.9904239,0.001031279,0.001221472,0.0007657982,0.0001136842,0.001051099,0.002918115,0.00002811091,0.002446592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003568365,"threshold_uncertainty_score":0.01193732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01006676472665592,"score_gpt":0.2585292153217141,"score_spread":0.2484624505950582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}